AMT vs MGNX · P/E 31, rev $10.64B vs rev $39.6M
American Tower Corp (AMT) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the AMT and MGNX stock pages for the full models.
Not investment advice.